Physician medical notes scaleup Heidi has acquired UK AI healthcare platform Automedica because it ramps up its give attention to synthetic intelligence.
The phrases of the deal weren’t disclosed, however the transfer underpins the Melbourne startup’s evolution from an AI scribe for GPs – it’s already supported greater than 100 million medical interactions globally – to a set of AI merchandise.
It follows $125m in enterprise funding raised by Heidi final yr, together with a $98 million series B in October, at a $703m valuation, and a $27m Series A top up seven months earlier.
Within the wake of the Automedica acquisition, the healthtech scaleup launched two new AI merchandise: Heidi Proof, to maintain docs updated with the newest medical information; and Heidi Comms, an AI companion for healthcare groups to coordinate every little thing from affected person communications and affected person care plans.
Heidi Proof is partly constructed on Claude, Anthropic’s AI fashions, to ship real-time medical insights throughout a session, supported by Automedica’s evidence-led AI framework.
Healthcare sandbox
Heidi cofounder and CEO Dr Thomas Kelly mentioned the strategic acquisition accelerates Heidi’s technical and regulatory capabilities and its UK presence, in addition to giving the startup entry to the MHRA AI Airlock, a regulatory sandbox for healthcare AI.
“We imagine that for AI to be a real care companion, the integrity of its proof should be non-negotiable,” he mentioned.
“As we see extra general-purpose AI platforms like OpenAI transfer towards ad-supported fashions, shoppers are rightly involved about hidden affect.”
Dr Kelly mentioned that in a healthcare setting, that concern turns into paramount.
“Bringing clear, clinical-grade insights into the room makes it simpler to ship high quality care, however that data should be free from the anomaly of business affect,” he mentioned.
“By committing to Proof being ad-free and unbiased, we guarantee clinicians can keep current with their sufferers, understanding their decision-making is constructed on pure medical rigour, not a enterprise mannequin.”
.
